StreetAlpha.app
Home › Stocks › ZTS

Zoetis Inc. (ZTS)

Healthcare
$83.46
▼ −1.14%
LAST CLOSE · NOV 17

Zoetis makes medicines, vaccines, diagnostic tests and other products that help veterinarians, farmers and pet owners care for animals. It last closed at $83.46 on Nov 17, down 1.14% on the day. ZTS reports earnings on Thu, Feb 11, 2027. The average 12-month price target from 4 analysts is $82.50 (-1.2% from the last close), with a high of $94.00 and a low of $74.00. Analyst consensus is Buy, based on the latest ratings from 4 firms (2 buy, 2 hold, 0 sell). Over the past 90 days StreetAlpha recorded 1 whale options trade in ZTS, 0% of them bullish and 100% bearish. In the past 30 days there were 9 dark pool prints totaling $9.8M, the largest $2.5M.

AI Auto Pilots
Is ZTS in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$9.5B
+0.9% vs a year ago
Net income
$2.5B
−4.7% vs a year ago
EPS (diluted)
$5.93
+0.7% vs a year ago
Free cash flow
$2.2B
23.5% margin
Valuation
Market cap
$33.9B
406.3M shares
P/E
14.1
Price over 12 month EPS
Price to sales
3.6
Market cap over revenue
Dividend yield
2.50%
$2.09 a share over 12 months
Balance sheet
Cash & equivalents
$1.3B
At Sep 30
Debt
$9.0B
At Sep 30
Shareholder equity
$3.3B
Buybacks
$3.8B
Last 12 months
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $7.8B$7.8BFY2021FY2022: $8.1B$8.1BFY2022FY2023: $8.5B$8.5BFY2023FY2024: $9.3B$9.3BFY2024FY2025: $9.5B$9.5BFY2025

From ZTS's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.

Next report
Feb 11
2027 · Time not announced
Consensus EPS forecast
$1.22
$2.18B revenue est.
Year-ago EPS
—
Not on file
Options-implied move
—
Posted about a week before
Analyst consensus
Buy
Based on 4 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Buy
4firms
2 Buy2 Hold0 Sell
Each firm's latest rating on ZTS in the past 90 days
Average 12-month target
$82.50
▼ 1.2% downside

Based on 4 analysts who set a price target on ZTS in the past 90 days. The average target is $82.50, with a high of $94.00 and a low of $74.00, compared with the last close of $83.46.

$67$77$86$96PAST 30 TRADING DAYS12-MONTH TARGETSHIGH $94AVG $82.50LOW $74May 22LAST CLOSE+12 MO$67$77$86$96PAST 30 DAYSTARGETSHIGH $94AVG $82.50LOW $74May 22LAST CLOSE+12 MO
Highest target$94.00
Average target$82.50
Lowest target$74.00
Latest rating changes
Morgan StanleyTarget lowered
Oct 29Buy$99 → $82
Goldman SachsInitiated
Oct 16Hold$74
TD CowenTarget lowered
Aug 25Buy$104 → $94
StifelTarget lowered
Aug 20Hold$85 → $80
CitigroupTarget lowered
Aug 11Buy$112 → $96
DateFirmActionRatingPrice target
Oct 29Morgan StanleyTarget loweredBuy$99 → $82
Oct 16Goldman SachsInitiatedHold$74
Aug 25TD CowenTarget loweredBuy$104 → $94
Aug 20StifelTarget loweredHold$85 → $80
Aug 11CitigroupTarget loweredBuy$112 → $96
Loading…

Technical Analysis

ZTS · as of the Nov 17 close · updated after every close
Bounce inside a longer downtrend

The stock is 2% above its 20 day and 8% above its 50 day average. It is 9% below its 200 day average, so the longer trend is down. Momentum is neutral (RSI 57). The nearest support is the Pivot S1 at $82.49, and the nearest resistance the Pivot at $84.02.

Short trendBullish
Long trendBearish
MomentumNeutral
StretchNormal
VolatilityHigh, 2.9%/day
Key levels
$132.4952 week high+58.7%
$91.08200 day average+9.1%
$89.25Swing high (Nov 4)+6.9%
$85.00Pivot R1+1.8%
$84.02Pivot+0.7%
$83.46Last close
$82.49Pivot S1−1.2%
$81.8520 day average−1.9%
$78.63Swing low (Nov 6)−5.8%
$76.6650 day average−8.1%
$76.09100 day average−8.8%
$68.7752 week low−17.6%
Indicators
RSI (14)57.30Middle of its rangeNeutral
MACD1.91Below its signal lineBearish
Stochastic55.2Middle of its rangeNeutral
ADX (14)32.3Trending up
Williams %R-50.4Oversold below −80, overbought above −20Neutral
CCI (20)84.9Oversold below −100, overbought above 100Neutral
Rate of change+0.6%Change over 10 sessionsBullish
ATR (14)$2.45Typical daily range, 2.9% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Below
What happened before, for ZTS

What happened before

See how ZTS did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow ZTS usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How ZTS has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2013.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Total alerts
1
Bullish
0
0%
Bearish
1
100%
Date span
Nov 12 – Nov 12
Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
9
Notional
$9.8M
Largest print
$2.5M
Loading…

ZTS Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bearish
Strongly bearishNeutralStrongly bullish
  • ▼610 buying vs 755 selling
  • ▼Held by funds -5.4 pts
  • ▼Funds holding -85
  • ●Superinvestors: 3 added, 3 cut
  • ▼Put/call 0.53 to 1.11
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding1,3541,439−5.9%
In funds' top 1089−11.1%
Held by funds93.0%98.3%−5.4 pts
New / increased126 / 484156 / 512−8.7%
Reduced / sold out559 / 196596 / 339−19.3%
Put/call ratio1.110.53+108.8%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See ZTS institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

ZTS Stock Buybacks

See all S&P 500 buybacks →
Spent, 12 months
$3.8B
11.1% yield
Left in program
$770.1M
2.3% of value
Shares outstanding, 12 months
−7.8%
Fewer shares
Last quarter
$499.8M
Sep 2026
Avg price paid, last quarter
$74.77
6.7M shares bought
S&P 500 rank by spending
#65 of 358
 
Spent each quarter, last 3 yearsTop bar $2.1B
Dec 2023: $235.8M, average price $174.19Mar 2024: $363.5M, average price $186.45Jun 2024: $532.5M, average price $167.00Sep 2024: $425.8M, average price $183.49Dec 2024: $552.5M, average price $177.26Mar 2025: $462.0M, average price $165.05Jun 2025: $337.2M, average price $157.48Sep 2025: $377.2M, average price $151.42Dec 2025: $2.1B, average price $124.31Mar 2026: $619.2M, average price $125.07Jun 2026: $550.2M, average price $88.59Sep 2026: $499.8M, average price $74.77
Dec 2023Sep 2026
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.

From the company's 10-Q filed Nov 5, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ZTS is in one of them and how their past ZTS trades turned out.

ZTS in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered ZTS in an article yet. Here's the latest on the wider market.

ZTS Congress Trades

All congress trades →
Trades, 12 months
58
Buys
29
50%
Sells
29
50%
People
7
Last filed Nov 17
Who traded ZTS · since 2015
Latest 5 filings of 204
$1K – $15KTraded Oct 2, 2026Filed Nov 17, 2026
$1K – $15KTraded Oct 2, 2026Filed Nov 17, 2026
$1K – $15KTraded Oct 13, 2026Filed Nov 5, 2026
$1K – $15KTraded Oct 7, 2026Filed Nov 5, 2026
$1K – $15KTraded Oct 21, 2026Filed Nov 4, 2026
PersonTypeAmountTradedFiledDelay
Byron DonaldsR · FLSell$1K – $15KOct 2, 2026Nov 17, 202646 d
Byron DonaldsR · FLSell$1K – $15KOct 2, 2026Nov 17, 202646 d
Ro KhannaD · CABuy$1K – $15KOct 13, 2026Nov 5, 202623 d
Ro KhannaD · CASell$1K – $15KOct 7, 2026Nov 5, 202629 d
Shelley CapitoR · WVSell$1K – $15KOct 21, 2026Nov 4, 202614 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Zoetis

Zoetis is an animal health company based in Parsippany, New Jersey. It develops and sells medicines, vaccines, diagnostic tests, genetic products and digital tools for pets and farm animals. Its customers include veterinarians, livestock producers and pet owners, and its products are sold in many countries. The company serves both companion animals and livestock across a range of species.

Headquarters
Parsippany, NJ
Founded
1952